THE WIRE
What insiders and companies just did: insiders buying and selling with their own money, company news, new 5% stakes and new shares registered.
BoughtSoldSold under a plan set in advanceCompany newsA 5% stakeNew shares registeredThe stock since the filing
Key
BoughtSoldSold under a plan set in advanceCompany newsA 5% stakeNew shares registeredThe stock since the filing
Newest first. Insider rows are open-market purchases and sales; several by one company are one row, open it for each.
- METAMeta Platforms, IncThe Chief Technology Officer sold $4.9M of stock under a 10b5-1 plan.$4.9M−5.9%Form 4 ↗
- ENPHEnphase Energy, IncA director sold $23.2M of stock.$23.2M−10.7%Form 4 ↗
- NWNNorthwest Natural Holding CoA director sold $77K of stock under a 10b5-1 plan.$77K+0.3%Form 4 ↗
- SEERSeer, IncThe VP Financial Planning Analysis sold $4K of stock.$4K−1.8%Form 4 ↗
- HTFLHeartflow, IncThe Chief Medical Officer sold $4.2M of stock under a 10b5-1 plan.$4.2M+4.6%Form 4 ↗
- NKTRNektar TherapeuticsThe President & CEO sold $15K of stock.$15K−7.2%Form 4 ↗
- NKTRNektar TherapeuticsThe Chief R&D Officer sold $7K of stock.$7K−7.2%Form 4 ↗
- LASRNlight, IncThe Chief Accounting Officer sold $7K of stock under a 10b5-1 plan.$7K−14.3%Form 4 ↗
- LEOBny Mellon Strategic Municipals, IncSaba Capital Management, a 10% owner, bought $431K of stock.$431K−0.5%Form 4 ↗
- VIKViking Holdings LtdThe EVP, Business Development sold $7.4M of stock under a 10b5-1 plan.$7.4M−1.0%Form 4 ↗
- LIDRAEye, IncA director bought $25K of stock.$25K−7.4%Form 4 ↗
- UTHRUNITED THERAPEUTICS CorpThe EVP & General Counsel sold $4.7M of stock under a 10b5-1 plan.$4.7M−0.8%Form 4 ↗
- KURAKura Oncology, IncThe Chief Commercial Officer sold $3K of stock under a 10b5-1 plan.$3K−6.0%Form 4 ↗
- DSMBny Mellon Strategic Municipal Bond Fund, IncSaba Capital Management, a 10% owner, bought $42K of stock.$42K−0.2%Form 4 ↗
- TEMTempus AI, IncThe EVP, Chief Legal Officer sold $422K of stock.$422K−9.3%Form 4 ↗
- TEMTempus AI, IncThe CEO and Chairman sold $1.1M of stock.$1.1M−9.3%Form 4 ↗
- TEMTempus AI, IncThe Chief Financial Officer sold $446K of stock.$446K−9.3%Form 4 ↗
- TEMTempus AI, IncThe CEO, Data sold $646K of stock.$646K−9.3%Form 4 ↗
- TEMTempus AI, IncThe Chief Accounting Officer sold $97K of stock.$97K−9.3%Form 4 ↗
- KNTKKinetik Holdings IncSadek Wahba, a 10% owner, sold $1.8M of stock.$1.8M−2.1%Form 4 ↗
- MXFMexico Fund IncSaba Capital Management, a 10% owner, bought $344K of stock.$344K−0.9%Form 4 ↗
- AAPLApple IncThe SVP, GC and Government Affairs sold $846K of stock under a 10b5-1 plan.$846K−1.9%Form 4 ↗
- TNGXTango Therapeutics, IncA director sold $80K of stock under a 10b5-1 plan.$80K−4.3%Form 4 ↗
- MGNIMagnite, IncA director sold $501K of stock.$501K−6.9%Form 4 ↗
- LEELEE ENTERPRISES, IncA director bought $121K of stock.$121K−0.8%Form 4 ↗
- GFNew Germany Fund IncSaba Capital Management, a 10% owner, bought $27K of stock.$27K−1.6%Form 4 ↗
- MATXMatson, IncThe Senior Vice President sold $321K of stock.$321K−1.8%Form 4 ↗
- CRAICra International, IncThe President and CEO sold $1.5M of stock under a 10b5-1 plan.$1.5M+1.7%Form 4 ↗
- BMRNBiomarin Pharmaceutical IncThe EVP, Chief R&D Officer sold $303K of stock.$303K−1.6%Form 4 ↗
- HFROHighland Opportunities & Income FundSaba Capital Management, a 10% owner, bought $67K of stock.$67K−2.9%Form 4 ↗
- FBIOFortress Biotech, IncThe President, CEO & Chairman bought $253K of stock.$253K+7.3%Form 4 ↗
- FBIOFortress Biotech, IncThe Chief Financial Officer bought $88K of stock.$88K+7.3%Form 4 ↗
- LCTXLineage Cell Therapeutics, IncA director bought $771K of stock.$771K−5.9%Form 4 ↗
- IMDXInsight Molecular Diagnostics IncNeal C Bradsher, a 10% owner, bought $6.0M of stock.$6.0M+18.7%Form 4 ↗
- RDZNRoadzen IncA director bought $17K of stock.$17K−1.7%Form 4 ↗
- WATTEnergous CorpA director sold $3K of stock under a 10b5-1 plan.$3K−9.2%Form 4 ↗
- PALProficient Auto Logistics, IncA director bought $78K of stock.$78K−3.2%Form 4 ↗
- PALProficient Auto Logistics, IncA director bought $84K of stock.$84K−3.2%Form 4 ↗
- APPFAppfolio IncThe Chief Executive Officer sold $443K of stock under a 10b5-1 plan.$443K−0.4%Form 4 ↗
- LUNRIntuitive Machines, IncAn officer sold $26K of stock.$26K−10.3%Form 4 ↗
- GRXGabelli Healthcare & WellnessRx TrustSaba Capital Management, a 10% owner, bought $11K of stock.$11K−1.1%Form 4 ↗
- JYNTJOINT CorpCharles E Jobson, a 10% owner, bought $379K of stock.$379K−3.7%Form 4 ↗
- CCBCoastal Financial CorpA director bought $550K of stock.$550K−1.5%Form 4 ↗
- GHGuardant Health, IncThe Chief People Officer sold $547K of stock under a 10b5-1 plan.$547K+0.2%Form 4 ↗
- BSMBlack Stone Minerals, LPThe Executive Chairman bought $338K of stock.$338K−0.7%Form 4 ↗
- FSBCFive Star BancorpThe President & CEO sold $61K of stock.$61K−2.1%Form 4 ↗
- IRTCiRhythm Holdings, IncA director bought $764K of stock.$764K+0.5%Form 4 ↗
- UHALU-Haul Holding CoMark V Shoen, a 10% owner, sold $2.2M of stock under a 10b5-1 plan.$2.2M−1.6%Form 4 ↗
- AFCGAdvanced Flower Capital IncA director bought $298K of stock.$298K−1.2%Form 4 ↗
- CVLTCommvault Systems IncThe Chief Accounting Officer sold $80K of stock under a 10b5-1 plan.$80K−4.2%Form 4 ↗